Related references
Note: Only part of the references are listed.Clinical efficacy and safety of efgartigimod for treatment of myasthenia gravis
Ajith Sivadasan et al.
IMMUNOTHERAPY (2023)
Neonatal Fc receptor blockade as emerging therapy in diseases with plasma exchange indications
Muharrem Yunce et al.
JOURNAL OF CLINICAL APHERESIS (2023)
Therapies in Stiff-Person Syndrome
Marinos C. Dalakas
Neurology-Neuroimmunology & Neuroinflammation (2023)
Stiff-person Syndrome and GAD Antibody-spectrum Disorders: GABAergic Neuronal Excitability, Immunopathogenesis and Update on Antibody Therapies
Marinos C. Dalakas
NEUROTHERAPEUTICS (2022)
Long-term Effectiveness of IVIg Maintenance Therapy in 36 Patients With GAD Antibody-Positive Stiff-Person Syndrome
Jessica Yi et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2022)
Plasma exchange in a bottle: An overview of efgartigimod for apheresis practitioners
Minh-Ha Tran
JOURNAL OF CLINICAL APHERESIS (2022)
Comparative Analysis of BIOCHIP Mosaic-Based Indirect Immunofluorescence with Enzyme-Linked Immunosorbent Assay for Diagnosing Myasthenia Gravis
Caterina Maria Gambino et al.
DIAGNOSTICS (2021)
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT) : a multicentre, randomised, placebo-controlled, phase 3 trial
James F. Jr Jr Howard et al.
LANCET NEUROLOGY (2021)
GAD antibody-spectrum disorders: progress in clinical phenotypes, immunopathogenesis and therapeutic interventions
Popianna Tsiortou et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2021)
Neurological Syndromes Associated with Anti-GAD Antibodies
Maelle Dade et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Intranasal midazolam for treating acute respiratory crises in a woman with stiff person syndrome
Giuseppe Cosentino et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)
Subcutaneous immunoglobulin for maintenance therapy in stiff-person syndrome: One-year follow-up in two patients
E. Fileccia et al.
NEUROMUSCULAR DISORDERS (2020)
Autologous hematopoietic stem cell transplantation for Stiff Person Spectrum Disorder: A clinical trial
Richard K Burt et al.
NEUROLOGY (2020)
Inflammatory polyradiculoneuropathies: Clinical and immunological aspects, current therapies, and future perspectives
Vincenzo Di Stefano et al.
EUROPEAN JOURNAL OF INFLAMMATION (2020)
Severe breathlessness in Stiff person syndrome (SPS). Looking under the bonnet
Grazia Crescimanno et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2020)
Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis
James F. Howard et al.
NEUROLOGY (2019)
Efgartigimod improves muscle weakness in a mouse model for muscle-specific kinase myasthenia gravis
Maartje G. Huijbers et al.
EXPERIMENTAL NEUROLOGY (2019)
Anti-glutamate Dehydrogenase Antibody Positive Cerebellar Ataxia and Stiff Person Syndrome Responding to Dual Treatment wit h Steroids and Intravenous Immunoglobulin; A Case Presentation and Literature Review
Furkan M. Yilmaz et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2019)
Improving Ambulation and Minimizing Disability with Therapeutic Plasma Exchange in a Stiff-person Syndrome Patient with Recurrent Falls
Kyle Sanchez et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2019)
Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans
Peter Ulrichts et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Kill 'Em All: Efgartigimod Immunotherapy for Autoimmune Diseases
Jagadeesh Bayry et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
Stiff-person syndrome after thymectomy in myasthenia gravis mimicking a post-thymectomy myasthenic crisis
Hye L. Lee et al.
NEUROLOGY INDIA (2017)
Myasthenia Gravis
Nils E. Gilhus
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Stiff-Person Syndrome Persistent Elevation of Glutamic Acid Decarboxylase Antibodies Despite Successful Treatment With Rituximab
Eugene A. Bacorro et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2010)